TERT-BUTYL 2-(4-CHLOROBENZO[D]THIAZOL-2-YL)ACETATE
![]() |
- $45 - $1366.53
- Product name: TERT-BUTYL 2-(4-CHLOROBENZO[D]THIAZOL-2-YL)ACETATE
- CAS: 1446332-71-3
- MF: C13H14ClNO2S
- MW: 283.77
- EINECS:
- MDL Number:MFCD26407285
- Synonyms:TERT-BUTYL 2-(4-CHLOROBENZO[D]THIAZOL-2-YL)ACETATE;t-butyl 2-(4-chloro-1,3-benzo[d]thiazol-2-yl)acetate;2-Benzothiazoleacetic acid, 4-chloro-, 1,1-dimethylethyl ester
4 prices
Selected condition:
Brand
- Alichem
- Crysdot
- TRC
Package
- 10mg
- 1g
- 5g
- ManufacturerAlichem
- Product number1446332713
- Product descriptiontert-Butyl2-(4-chlorobenzo[d]thiazol-2-yl)acetate
- Packaging1g
- Price$441.98
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1446332713
- Product descriptiontert-Butyl2-(4-chlorobenzo[d]thiazol-2-yl)acetate
- Packaging5g
- Price$1366.53
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11254998
- Product descriptiontert-Butyl2-(4-chlorobenzo[d]thiazol-2-yl)acetate 97%
- Packaging1g
- Price$496
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB812625
- Product descriptionTert-Butyl2-(4-Chlorobenzo[D]Thiazol-2-Yl)Acetate
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1446332713 | tert-Butyl2-(4-chlorobenzo[d]thiazol-2-yl)acetate | 1g | $441.98 | 2021-12-16 | Buy |
Alichem | 1446332713 | tert-Butyl2-(4-chlorobenzo[d]thiazol-2-yl)acetate | 5g | $1366.53 | 2021-12-16 | Buy |
Crysdot | CD11254998 | tert-Butyl2-(4-chlorobenzo[d]thiazol-2-yl)acetate 97% | 1g | $496 | 2021-12-16 | Buy |
TRC | B812625 | Tert-Butyl2-(4-Chlorobenzo[D]Thiazol-2-Yl)Acetate | 10mg | $45 | 2021-12-16 | Buy |
Properties
Boiling point :377.0±22.0 °C(Predicted)
Density :1.286±0.06 g/cm3(Predicted)
pka :-1.14±0.10(Predicted)
Density :1.286±0.06 g/cm3(Predicted)
pka :-1.14±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|